← Back to Search

Educational Media Interventions for Cancer (ADELANTE Trial)

N/A
Recruiting
Led By Lisa Kachnic, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients with non-metastatic prostate or breast cancer
Karnofsky performance status 70 or greater
Must not have
RT for sites other than breast or prostate
Prior RT
Timeline
Screening 3 weeks
Treatment Varies
Follow Up following completion of rt (4-6 weeks from enrollment for breast cancer, 4-9 weeks for prostate cancer), for up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is studying how well educational media interventions work in preparing Latinx Spanish-speaking patients for radiation therapy for breast or prostate cancer and in fostering receptivity to and informed decision-making around cancer clinical trial participation.

Who is the study for?
This trial is for Latinx Spanish-speaking individuals with a confirmed diagnosis of non-metastatic breast or prostate cancer. They must have a Karnofsky performance status of 70 or above, indicating they are able to care for themselves. Women who can bear children need pregnancy tests as per guidelines. Participants should be planning to receive or currently undergoing curative radiation therapy and must consult using a certified interpreter.
What is being tested?
The study is testing educational media interventions designed to help Latinx patients understand radiation therapy for breast or prostate cancer and encourage informed participation in clinical trials. It includes an audiovisual education program on radiation therapy and brochures from ASTRO and NCI about cancer treatments and research studies.
What are the potential side effects?
Since this trial focuses on educational materials rather than medical treatments, there are no direct side effects related to drugs or therapies being tested. However, participants may experience emotional responses to the information provided.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My cancer has not spread beyond my prostate or breast.
Select...
I am able to care for myself but cannot do normal activities without help.
Select...
I have been diagnosed with prostate or breast cancer through a tissue examination.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have received radiation therapy for areas other than my breast or prostate.
Select...
I have previously undergone radiation therapy.
Select...
My cancer has spread to other parts of my body.
Select...
I am deaf and/or blind in both ears/eyes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~following completion of rt (4-6 weeks from enrollment for breast cancer, 4-9 weeks for prostate cancer), for up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and following completion of rt (4-6 weeks from enrollment for breast cancer, 4-9 weeks for prostate cancer), for up to 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Radiation Therapy (RT) Adherence Score
Radiation Therapy (RT) Knowledge Questionnaire
Radiation Therapy (RT) Satisfaction Questionnaire
Secondary study objectives
Clinical Trials Perceptivity Questionnaire
Clinical trial enrollment

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Audiovisual Intervention- Radiation Therapy EducationExperimental Treatment1 Intervention
Audiovisual video will be provided to the subjects as educational material.
Group II: Audiovisual Intervention- Cancer Clinical TrialsExperimental Treatment1 Intervention
Audiovisual video will be provided to the subjects as educational material.
Group III: Written Brochure- Radiation Therapy EducationActive Control1 Intervention
Written brochures will be provided to the subjects as educational material.
Group IV: Written Brochure- Cancer Clinical TrialsActive Control1 Intervention
Written brochures will be provided to the subjects as educational material.

Find a Location

Who is running the clinical trial?

VarianUNKNOWN
4 Previous Clinical Trials
186 Total Patients Enrolled
Columbia UniversityLead Sponsor
1,498 Previous Clinical Trials
2,766,931 Total Patients Enrolled
30 Trials studying Breast Cancer
23,654 Patients Enrolled for Breast Cancer
Varian Medical SystemsIndustry Sponsor
62 Previous Clinical Trials
3,558 Total Patients Enrolled
3 Trials studying Breast Cancer
362 Patients Enrolled for Breast Cancer
Lisa Kachnic, MDPrincipal InvestigatorColumbia University
1 Previous Clinical Trials
20 Total Patients Enrolled

Media Library

Audiovisual Intervention- Cancer Clinical Trials Education Clinical Trial Eligibility Overview. Trial Name: NCT05351424 — N/A
Breast Cancer Research Study Groups: Written Brochure- Radiation Therapy Education, Audiovisual Intervention- Cancer Clinical Trials, Written Brochure- Cancer Clinical Trials, Audiovisual Intervention- Radiation Therapy Education
Breast Cancer Clinical Trial 2023: Audiovisual Intervention- Cancer Clinical Trials Education Highlights & Side Effects. Trial Name: NCT05351424 — N/A
Audiovisual Intervention- Cancer Clinical Trials Education 2023 Treatment Timeline for Medical Study. Trial Name: NCT05351424 — N/A
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top